MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could CAR T-Cells tame MS? new trial begins
Disease control Not yet recruitingThis early-stage study tests a new treatment called CABA-201 for people with multiple sclerosis (MS). It uses a patient's own immune cells, modified to target and destroy certain immune cells that may be attacking the nervous system. The main goals are to check safety and see if …
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
Taurine supplement tested as Add-On therapy for MS
Disease control Not yet recruitingThis study tests whether taking taurine, a natural supplement, alongside standard multiple sclerosis (MS) medications can help control the disease better than medications alone. About 80 adults with relapsing-remitting MS will take taurine or continue their usual treatment for 24…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 02:45 UTC
-
New MS drug trial uses Super-Strength MRI to see inside the brain
Disease control Not yet recruitingThis study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years, and researchers use ultra-powerful 7T MRI scans to measure changes in brain volume, lesions, and tissu…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Lifestyle makeover aims to ease MS symptoms
Symptom relief Not yet recruitingThis study tests whether a 12-week program focused on nutrition, exercise, sleep, and stress management can improve fatigue, physical function, and quality of life in 30 adults with relapsing-remitting multiple sclerosis. Participants first undergo a 12-week observation period, t…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: New York University Abu Dhabi • Aim: Symptom relief
Last updated May 26, 2026 02:57 UTC
-
MS mystery: do relapses strike without a trace on MRI?
Knowledge-focused Not yet recruitingThis study looks at whether people with relapsing-remitting multiple sclerosis (MS) can have a relapse without any new spots showing up on an MRI scan. Researchers will follow 136 adults who are having a suspected relapse, giving them an MRI within 6 days and checking on them 6 m…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 26, 2026 02:44 UTC